Interferon-γ Drives T reg Fragility to Promote Anti-tumor Immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon-γ Drives T reg Fragility to Promote Anti-tumor Immunity

Published:2017-06 Issue:6 Volume:169 Page:1130-1141.e11
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Overacre-Delgoffe Abigail E.,Chikina Maria,Dadey Rebekah E.,Yano Hiroshi,Brunazzi Erin A.,Shayan Gulidanna,Horne William,Moskovitz Jessica M.,Kolls Jay K.,Sander Cindy,Shuai Yongli,Normolle Daniel P.,Kirkwood John M.,Ferris Robert L.,Delgoffe Greg M.,Bruno Tullia C.,Workman Creg J.,Vignali Dario A.A.

Funder

NIH

NCI Comprehensive Cancer Center Support CORE

NCI SPORE

American Lebanese Syrian Associated Charities

UPSOM Unified Flow Core

UPCI Flow Core

NCI

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference66 articles.

1. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer;Battaglia;Immunology,2008

2. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer;Battaglia;Cancer Immunol. Immunother.,2009

3. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals;Battle;Genome Res.,2014

4. X chromosome inactivation: recent advances and a look forward;Briggs;Curr. Opin. Genet. Dev.,2014

5. Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases;Chaudhary;Expert Opin. Ther. Targets,2015

Cited by 452 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration;Current Gene Therapy;2025-04

2. Altered characteristics of regulatory T cells in target tissues of Sjögren’s syndrome in murine models;Molecular Immunology;2024-10

3. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04

4. Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations;Frontiers in Immunology;2024-09-03

5. Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends;Experimental & Molecular Medicine;2024-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3